v3.26.1
Revenue
 3 Months Ended
Mar. 31, 2026
Revenue Recognition [Abstract]  
Revenue Revenue
The following table presents the Company’s disaggregated revenue by offering type (in thousands):
 Three Months Ended
March 31,
 20262025
 
Total Net
Revenues
Percentage of
Total Net
Revenues
Total Net
Revenues
Percentage of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products$673 2.0 %$638 1.8 %
Third-Party Payer products4,868 14.5 %3,951 11.4 %
Patient Services revenue recognized over time:
Direct rental services1,963 5.8 %1,914 5.5 %
Third-Party Payer rental services12,484 37.1 %12,215 35.2 %
Total Patient Services accounted for under ASC 60619,988 59.3 %18,718 53.9 %
Device Solutions revenue recognized at a point in time:
Products3,335 9.9 %4,002 11.5 %
Services
2,792 8.3 %2,350 6.8 %
Device Solutions revenue recognized over time:
Services
149 0.4 %1,855 5.3 %
Total Device Solutions accounted for under ASC 6066,276 18.6 %8,207 23.6 %
Total Revenue Accounted for under ASC 60626,264 78.0 %26,925 77.6 %
Patient Services lease revenue
2,117 6.3 %2,056 5.9 %
Device Solutions lease revenue
5,303 15.7 %5,735 16.5 %
Total Revenue accounted for under ASC 842, Leases7,420 22.0 %7,791 22.4 %
Total Net Revenue$33,684 100.0 %$34,716100.0 %
Contract Balances
(dollars in thousands)
As of March 31, 2026
As of December 31, 2025
$ Change
Accounts receivable, net$23,980 $22,901 $1,079 
Contract assets$1,222 $1,244 $(22)
Contract liabilities$156 $109 $47 
The change in contract assets during the three months ended March 31, 2026 included $0.9 million of revenue recognized for which the payment is subject to conditions other than the passage of time, which was partially offset by $0.9 million of contract assets reclassified to accounts receivable as our right to consideration for these contract assets became unconditional. Contract assets are included in other current assets on the Company's condensed consolidated balance sheets. As of December 31, 2024, accounts receivable, net, and contract assets were $21.2 million and $0.6 million, respectively. As of December 31, 2024, there were no contract liabilities. Revenue recognized during the three months ended March 31, 2026 that was included in the contract liabilities at the beginning of the period was $0.1 million. The allowance for credit losses was $0.3 million as of both March 31, 2026 and December 31, 2025.